Periodontal health status, Porphyromonas gingivalis and anti-cyclic citrullinated peptide antibodies among rheumatoid arthritis patients

被引:0
|
作者
Jiun, Tan Wan [1 ]
Taib, Haslina [2 ,6 ]
Mohamad, Wan Majdiah Wan [3 ]
Mohamad, Suharni [4 ]
Ghazali, Wan Syamimee Wan [5 ]
机构
[1] Klinik Pergigian Cahaya Suria, Unit Periodontik, 7 Jalan 3-12, Kuala Lumpur 50050, Malaysia
[2] Univ Sains Malaysia, Sch Dent Sci, Periodont Unit, Hlth Campus, Kota Baharu 16150, Kelantan, Malaysia
[3] Hlth Campus Univ Sains Malaysia, Sch Dent Sci, Immunol Unit, Kota Baharu 16150, Kelantan, Malaysia
[4] Univ Sains Malaysia, Sch Dent Sci, Microbiol Unit, Hlth Campus, Kota Baharu 16150, Kelantan, Malaysia
[5] Univ Sains Malaysia, Sch Med Sci, Med Dept, Hlth Campus, Kota Baharu 16150, Kelantan, Malaysia
[6] Univ Sains Malaysia, Hosp Univ Sains Malaysia, Sch Dent Sci, Hlth Campus, Kota Baharu 16150, Kelantan, Malaysia
关键词
Porphyromonas gingivalis; Periodontitis; Rheumatoid arthritis; Anti -cyclic citrullinated peptide; PORPHYROMONAS-GINGIVALIS; TANNERELLA-FORSYTHIA; TREPONEMA-DENTICOLA; DISEASE; ACTINOMYCETEMCOMITANS; ASSOCIATION; PARAMETERS; SEVERITY;
D O I
10.1016/j.intimp.2023.110940
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Porphyromonas gingivalis (P. gingivalis) is the primary periodontal pathogen involved in protein citrullination, which triggers the production of anti-cyclic citrullinated peptide (anti-CCP) antibodies, exacerbating rheumatoid arthritis (RA). This study aims to evaluate the amount of P. gingivalis and its association with anti-CCP antibodies in RA patients with periodontitis. This cross-sectional study involves 100 RA patients with a mean age of 52.36 (SD 13.90) years. Smokers and patients with other uncontrolled systemic diseases were excluded. Disease Ac-tivity Score-28 (DAS-28) was used to determine RA disease severity. Periodontal parameters were examined to determine periodontal status. Subsequently, plaque samples were collected from the subgingival periodontal pocket for assessment of P. gingivalis bacterial load using the loop-mediated isothermal amplification method. Blood samples (5 ml) were obtained from all participants to analyse anti-CCP antibody levels. Data was analysed by using SPSS version 24.0. Most participants were female (85.0%) and had low RA disease severity (62%). The mean RA disease duration was 7.77 (SD 6.3) years, with a mean DAS-28 of 3.17 (SD 1.0). Forty-seven per cent of participants had periodontitis, but all periodontal parameters were not associated with RA disease activity (P = 0.38). P. gingivalis bacterial load ranged from 10 to 109 copies/mu l. Fifty-five per cent of the collected samples showed positive anti-CCP antibody levels, but no significant association was observed with the P. gingivalis bacterial load (P = 0.58). Considering the study's limitations, although periodontitis is prevalent among RA patients, there is a lack of association between P. gingivalis bacterial load and anti-CCP antibody levels, which should be investigated further.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Diagnostic value of anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis treated with etanercept
    Drynda, S.
    Wollenberg, H.
    Khne, C.
    Polter, J.
    Kekow, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : A21 - A22
  • [32] THE DIAGNOSTIC UTILITY OF ANTI-MUTATED CITRULLINATED VIMENTIN ANTIBODIES, ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES AND RHEUMATOID FACTOR IN RHEUMATOID ARTHRITIS
    Eldin, A. Radr
    Mobasher, S. A.
    Hegazy, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 898 - 898
  • [33] Diagnostic utility of anti-cyclic citrullinated peptide and anti-modified citrullinated vimentin antibodies in rheumatoid arthritis
    Keskin, Goksal
    Inal, Ali
    Keskin, Dilek
    Pekel, Aysel
    Baysal, Ozan
    Dizer, Ufuk
    Sengul, Ali
    PROTEIN AND PEPTIDE LETTERS, 2008, 15 (03): : 314 - 317
  • [34] Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis, brucellar arthritis and Behcet's disease
    Aridogan, Buket Cicioglu
    Cetin, Emel Sesli
    Yildirim, Mehmet
    Kaya, Selcuk
    Ceyhan, Ali Murat
    Demirci, Mustafa
    Savas, Serpil
    Ural, Onur
    Akkus, Selami
    AFRICAN JOURNAL OF MICROBIOLOGY RESEARCH, 2011, 5 (19): : 2975 - 2979
  • [35] Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis
    De Rycke, L
    Verhelst, X
    Kruithof, E
    Van den Bosch, F
    Hoffman, IEA
    Veys, EM
    De Keyser, F
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) : 299 - 302
  • [36] Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis
    Matsui, Toshihiro
    Shimada, Kota
    Ozawa, Naoko
    Hayakawa, Hiromi
    Hagiwara, Futoshi
    Nakayama, Hisanori
    Sugii, Shoji
    Ozawa, Yoshinori
    Tohma, Shigeto
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (12) : 2390 - 2397
  • [37] Bleeding in Rheumatoid Arthritis: Association Between Hypofibrinogenemia and Anti-cyclic Citrullinated Peptide Antibodies?
    Fernandez-Mosteirin, N.
    Calvo Villas, J. M.
    HAEMOPHILIA, 2017, 23 : 111 - 111
  • [38] Anti-Cyclic Citrullinated Peptide Antibodies and Severity of Interstitial Lung Disease with Rheumatoid Arthritis
    Yamasaki, Masaomi
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [39] Pathogenic Role of Circulating Citrullinated Antigens and Anti-Cyclic Monoclonal Citrullinated Peptide Antibodies in Rheumatoid Arthritis
    Won, Pureun
    Kim, Youngkyun
    Jung, Hyerin
    Rim, Yeri Alice
    Sohn, Dong Hyun
    Robinson, William H.
    Moon, Su-Jin
    Ju, Ji Hyeon
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [40] Anti-cyclic citrullinated peptide antibodies: a comparison of different assays for the diagnosis of rheumatoid arthritis
    Debaugnies, F.
    Servais, G.
    Badot, V.
    Noubouossie, D.
    Willems, D.
    Corazza, F.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2013, 42 (02) : 108 - 114